Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Clinical Research Coordination Services

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract for Clinical Research Coordination Services supports the Department of Defense and the Defense Health Agency Contracting Activity in managing clinical trial extensions for breast cancer research projects. The selected provider will be responsible for the day-to-day management of patient cohorts and the coordination of clinical sites, ensuring all activities adhere to IRB compliance and Good Clinical Practice certification. Key technical requirements include the use of Clinical Trial Management Systems and Electronic Data Capture software to deliver enrolled patient cohorts. The contractor must ensure strict adherence to SPIRIT and STROBE reporting guidelines and maintain up-to-date records within the National Clinical Trial registry. This opportunity falls under NAICS code 541710 and was posted on September 3, 2026, with a response deadline of November 18, 2026.

General Info

Subcontract for DoD breast cancer clinical trial coordination and patient cohort management.

Documents

This scope was carved out of HT942526BCRPCREA2.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

DoW Breast Cancer, Clinical Research Extension Award

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency Contracting Activity - Dhaca
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Performs day-to-day management of clinical trial extensions for prime contractors on Department of Defense breast cancer research projects. Manages patient cohorts, coordinates clinical sites, and ensures compliance with SPIRIT and STROBE reporting guidelines and National Clinical Trial (NCT) registry updates. Utilizes Clinical Trial Management Systems (CTMS) and Electronic Data Capture (EDC) software. Requires GCP certification and IRB compliance. Delivers enrolled patient cohorts.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → Defense Health Agency Contracting Activity - Dhaca

Same awarding agency

NAICS: 541715
Grant
DoW Breast Cancer, Breakthrough Award Levels 1 and 2
Solicitation # HT942526BCRPBTA122
The Defense Health Agency Contracting Activity is soliciting applications for the Fiscal Year 2026 Breast Cancer Research Program Breakthrough Award Levels 1 and 2 under solicitation HT942526BCRPBTA122. This program aims to fund high-impact research capable of producing breakthroughs in breast cancer treatment and understanding. Funding Level 1 supports early-stage, high-risk, high-reward research focused on proof of concept without requiring preliminary data, while Funding Level 2 supports research validated by substantial preliminary or published data to facilitate clinical translation. A specialized Population Science Studies option is available under Level 2. The program expects to allot approximately 10.6 million dollars to fund roughly six applications. Eligible applicants may apply as a single Principal Investigator or through a Partnering PI Option. Funding limits vary by level and PI structure, ranging from 750,000 dollars for a single PI at Level 1 up to 3.35 million dollars for partnering PIs conducting Population Science Studies at Level 2. The maximum period of performance is three years, extending to four years for Population Science Studies. Applications are evaluated based on impact, research strategy, and feasibility, with personnel and partnership qualifications also considered. The application process is a two-step submission requiring a pre-application by November 4, 2026, and a full application by November 18, 2026. Required documentation includes a project narrative, statement of work, and various abstracts and statements submitted as specific PDF attachments. Applicant organizations must maintain active registration in SAM.gov and provide a Unique Entity Identifier. Additionally, all key personnel must disclose foreign affiliations, and clinical research proposals must include a Public Health Service Inclusion Enrollment Report.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 2 months ago

DEADLINE

in 28 days
View Details
NAICS: 541715
Grant
DoW Breast Cancer, Clinical Research Extension Award
Solicitation # HT942526BCRPCREA2
The FY26 Breast Cancer Research Program Clinical Research Extension Award, solicitation HT942526BCRPCREA2, is a grant opportunity issued by the Defense Health Agency Contracting Activity to support research that extends data collection, follow-up, and analysis of breast cancer clinical studies. The program aims to recover knowledge lost due to early trial termination, limited patient follow-up, or suboptimal data collection, including projects involving deeper molecular analysis of clinical samples. All applications must address at least one FY26 BCRP overarching challenge. The research team is required to include at least two breast cancer consumer advocates. Funding allows for a single Principal Investigator or a partnering arrangement between an Initiating PI and a Partnering PI. The application process is a two-step submission requiring a pre-application Letter of Intent by November 4, 2026, and a full application by November 18, 2026. Pre-applications are submitted via eBRAP, while full applications are submitted through eBRAP for intramural DOW organizations and Grants.gov for extramural organizations. Awards have a maximum period of performance of four years. Evaluation follows a two-tier system consisting of a peer review for technical merit and a programmatic review for relevance. Scored criteria include impact, research strategy and feasibility, partnership (for PPIO applications), and the research sharing plan. Applicants must be registered in SAM.gov with an active status and a Unique Entity Identifier.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 2 months ago

DEADLINE

in 28 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS